Page 2 - Drug Pricing Program News Today

Going to our schools and making our neighborhood safe. But unfortunately even our residents that have good coverage are spending this money on medications. There are a lot of complicated issues that under lie why drug pricing is so high. There are a couple things that i would like to note that i have certainly explored with city staff on this issue. We have very little transparency on the prices set not only with drugs but also prices paid by the city and county of San Francisco. Some of the out...

Fairs. However their response is they have made previous attempts to do so and have not had support of sf mta and policy makers. Mta is here to speak on this one outstanding issue. Good morning, chair breed, supervisor tang. A little bit, my name is cameron sammy. Im the enforcement manager with sf mta. A little background. Article 6 temporary use of or occupancy of public streets sf mta, the ability to collect fees from major events which are defined in section 6. 3. There is three primarily is...

Proudly invite guests from as far away as the far east. Some of the original customers im not sure where the far east is that. Is that the east coast or is that the far east of the world . Because im not clear about that. I think its maybe asia is what were talking about. Some of the original customers come back with their children and grandchildren to reminisce about those good old days. In fact, the excelsior district there are a lot of people who like to reminisce about the good old days and ...

In the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit...

Judges ruled in favor of drug manufacturers ability to limit sales and distribution of discounted drugs in the governments 340B drug pricing program.

Healthcare

An appeals court has upheld a lower court ruling on 340B that sided with drug manufacturers. At issue is whether pharmaceutical companies can limit distribution of discounted drugs in the 340B program. The U.S. Court of Appeals for the District of Columbia has said that they can. The May 21 ruling issued by Circuit Court Judge Gregory Katsas found for Novartis Pharmaceuticals

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.

A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 -- the 340B Drug Pricing Nondiscrimination Act.